Biochemistry, Genetics and Molecular Biology
Mesenchymal-Epithelial Transition
59%
Cancer Cell
46%
Cancer Stem Cell
42%
Tumor Progression
31%
Drug Resistance
25%
Stem Cell
21%
Cadherin
19%
Dynamics
19%
Stromal Cell
17%
Mouse Model
14%
Carcinogenesis
13%
MicroRNA
13%
Messenger RNA
12%
Cell Fate
12%
Immune Evasion
12%
Mouse
12%
Cell Migration
12%
Notch
11%
Micrococcal Nuclease
11%
Mir-200
11%
ZEB1
10%
ZEB2
10%
Embryogenesis
10%
Transcription Factors
10%
Cell Activity
10%
Animal Model
10%
Target Organ
10%
Functional Genomics
9%
Wnt Signaling Pathway
9%
Drive
9%
Phosphoglycerate Mutase
9%
SNAI2
9%
Contig
9%
Folic Acid
9%
Oncogene
9%
MTDH
9%
Secretome
9%
Genetics
9%
RNA
9%
Mediator
9%
T Cell
8%
Experimental Model
8%
Cell Lineage
8%
Signal Transduction
7%
Tumor Suppressor Protein
6%
Small Molecule
6%
CRISPR
6%
Cancer Staging
6%
Mason-Pfizer Monkey Virus
6%
RNA Recognition Motif
6%
Small Hairpin RNA
6%
Macrophage
6%
Notch Signaling Pathway
6%
Enzyme
6%
Natural Killer Cell
6%
DNA Methylation
5%
RNA Binding
5%
Homeostasis
5%
Osteoblast
5%
Colony Formation
5%
Cell Plasticity
5%
Genetically Engineered Mouse Strain
5%
Angiogenesis
5%
Crystal Structure
5%
P53
5%
SND1
5%
Luciferase
5%
Medicine and Dentistry
Metastatic Carcinoma
100%
Breast Cancer
57%
Bone Metastasis
36%
Cancer Growth
24%
Tumor Cell
19%
Neoplasm
19%
Malignant Neoplasm
15%
Cancer Cell
12%
Metastatic Breast Cancer
11%
Epithelial Mesenchymal Transition
10%
Protein Jagged 1
9%
Prostate Cancer
9%
Functional Genomics
8%
Cell Lineage
8%
Cell Plasticity
8%
Dormancy
7%
Cancer Stem Cell
6%
Progenitor Cell
6%
Brain Metastasis
6%
Circulating Tumor Cell
6%
Catheter Ablation
6%
Triple Negative Breast Cancer
6%
Stromal Tumor
5%
Mesenchymal-Epithelial Transition
5%
Keyphrases
Metastasis
25%
Metadherin
19%
Chemoresistance
17%
Breast Cancer Bone Metastasis
14%
Cancer Stem Cells
13%
Cancer Metastasis
12%
Breast Cancer
11%
Metastatic Breast Cancer
10%
Triple-negative Breast Cancer
9%
Phosphoglycerate mutase
9%
Mammary Stem Cells
9%
Jagged1
9%
Hysteresis Control
9%
Nuclear RNA Export
9%
Pro-metastatic
9%
Smad
9%
Tumor Suppressor Activity
9%
DLL1
9%
Therapeutic Target
9%
MiR-200
9%
Cancer Progression
7%
Internal Promoter
7%
Novel Therapeutics
7%
3-phosphoglycerate
6%
In Cancer
6%
Tumor
6%
Tumor-initiating Cells
6%
Bone Marrow Cells
6%
Malignancy
6%
Primary Cancer
5%
Constitutive Transport Element
5%
Breast Cancer Progression
5%
TINAGL1
5%
Melanoma Cells
5%
Metastatic Ability
5%
Circulating Tumor Cells
5%
Cancer Cell Proliferation
5%
Simian Foamy Virus
5%
Metastatic Cancer
5%
Bone Metastasis
5%
Disseminated Tumor Cells
5%
Cancer Patients
5%
Tumor Dissemination
5%
Primary Tumor
5%
